European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 3.900
-0.140 (-3.47%)
Sep 18, 2026, 3:58 PM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €16.5 million as of September 18, 2026. Its market cap has decreased by -16.12% in one year.
Market Cap
16.50M
Enterprise Value
32.68M
Revenue
51.36M
Ranking
n/a
PE Ratio
8.02
Stock Price
€3.90
ChartMarket Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 16.50M, a decrease of -80.83%. That is a compound annual growth rate of -14.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 16.50M | -25.00% |
| Dec 31, 2025 | 22.01M | -13.33% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 54.28B |
| UCB SA | 39.77B |
| Financière de Tubize | 7.91B |
| Onward Medical | 200.94M |
| Hyloris Pharmaceuticals | 118.16M |
| Celyad Oncology | 10.79M |
| BioSenic | 1.31M |
| Oxurion NV | 394.06K |